Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D08DVL
|
|||
Former ID |
DNC013447
|
|||
Drug Name |
3-(4-(o-toluidino)pyrimidin-2-ylamino)benzamide
|
|||
Synonyms |
2,4-dianilino pyrimidine, 8; CHEMBL400798; BDBM26151
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H17N5O
|
|||
Canonical SMILES |
CC1=CC=CC=C1NC2=NC(=NC=C2)NC3=CC=CC(=C3)C(=O)N
|
|||
InChI |
1S/C18H17N5O/c1-12-5-2-3-8-15(12)22-16-9-10-20-18(23-16)21-14-7-4-6-13(11-14)17(19)24/h2-11H,1H3,(H2,19,24)(H2,20,21,22,23)
|
|||
InChIKey |
ZUJLZMHZCZZHLN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | N-4-Pyrimidinyl-1H-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4363-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.